Viscosupplementation System Market to Signify Strong Growth by 2023-2029
Viscosupplementation System Market is anticipated to grow at a CAGR of around 8.6% during the forecast period. The key factors that driving market growth include the increasing prevalence of osteoarthritis across the globe coupled with the rising demand for viscosupplementation. For instance, according to Centre for Disease Control and Prevention estimation of 1 in 4 (or 54.4 million), Although there are more than 100 types of arthritis, osteoarthritis (OA) is the most common, affecting 32.5 million adults in the US. Adults in the US suffer from arthritis, with the number expected to rise to 78 million by 2040. Further, improvement in healthcare infrastructure and providence of medical assistance also drive the market. For instance, according to Commonwealth Fund, in 2018, almost 92% of the population got medical insurance coverage in the US and almost 55% population was covered under Employer-sponsored health insurance.
Moreover,
significant advancement in the viscosupplementation by the major players in the
market also propel the growth of the market. For instance, in January 2019,
OrthogenRx introduced TriVisc, a sodium hyaluronate for the treatment of knee
osteoarthritis in a three-injection regimen in the US. TriVisc is the least
expensive in terms of price and this launch will be allowing OrthogenRx to stay
the course in providing healthcare practitioners and patients with reasonable
and reliable pricing for all goods.
To Request a
Sample of our Report on Viscosupplementation System Market: https://www.omrglobal.com/request-sample/viscosupplementation-market
Market Coverage
· The
market number available for – 2022-2029
· Base
year- 2022
· Forecast
period- 2023-2029
Segment Covered-
· By
Product
· By
Application
Regions Covered-
· North
America
· Europe
· Asia-Pacific
· Rest
of the World
· Competitive
Landscape- Anika Therapeutics, Inc., LG chem., Smith & Nephew Plc,
Seikagaku Corp., Lifecore Biomedical, LLC, Sanofi S.A., Zimmer Biomet Holdings,
Inc., and others
Viscosupplementation Market
Report Segment
By Product
· Single-Injection
· Three-Injection
· Five-Injection
By Application
· Knee
· Hip
· Ankle
· Others
A full Report of
Viscosupplementation System Market is Available at: https://www.omrglobal.com/industry-reports/viscosupplementation-market
Viscosupplementation Market Report
Segment by Region
North America
United States
Canada
Europe
· UK
· Germany
· Spain
· France
· Italy
· Rest
of Europe
Asia-Pacific
· India
· China
· Japan
· South
Korea
· Rest
of APAC
Rest of the World
· Latin
America
· Middle
East & Africa
Company
Profiles
· Anika
Therapeutics, Inc.
· Ferring
B.V.
· Fidia
Farmaceutici S.p.A
· Johnson
& Johnson Services, Inc.
· KalVista
Pharmaceuticals, Inc.
· LG
Chem (Life Sciences)
· Lifecore
Biomedical, LLC
· Maxigen
Biotech, Inc.
· Pharmascience
Inc.(PendoPharm)
· Regen
Lab SA
· Sanofi
S.A.
· Seikagaku
Corp.
· Shanghai
Haohai Biological Technology Co., Ltd.
· Smith
& Nephew PLC
· Stellar
Pharmaceuticals, Inc.
· Stryker
Corp.
· Swiss
Biomed Orthopaedics AG
· Virchow
Biotech Pvt. Ltd.
· Zimmer
Biomet Holdings, Inc.
Reasons to buy
from us –
1. We
cover more than 15 major industries, further segmented into more than 90
sectors.
2. More
than 120 countries are for analysis.
3. Over
100+ paid data sources mined for investigation.
4. Our
expert research analysts answer all your questions before and after purchasing
your report.
For More
Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/viscosupplementation-market
About Orion
Market Research
Orion
Market Research (OMR) is a market research and consulting company known for its
crisp and concise reports. The company is equipped with an experienced team of
analysts and consultants. OMR offers quality syndicated research reports,
customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion
Market Research
Contact Person: Mr.
Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91
7803040404
Comments
Post a Comment